Identification Module
The Identification Module contains basic identifying information about the clinical trial, including the NCT ID, brief title, official title, acronym, organization study ID information, and organization details. This module provides essential identifiers for the trial.
Identification Module path is as follows:
Study -> Protocol Section -> Identification Module
Identification Module
Ignite Creation Date:
2025-12-25 @ 4:04 AM
Ignite Modification Date:
2025-12-25 @ 4:04 AM
NCT ID:
NCT00193102
Brief Title:
Thalidomide in Combination With Capecitabine in Patients With Metastatic Breast Cancer
Official Title:
Phase II Study of Thalidomide in Combination With Capecitabine in Patients With Metastatic Breast Cancer
Study:
NCT00193102
Protocol Section:
NCT00193102